Please login to the form below
Emerging Companies
This page shows the latest Emerging Companies news and features for those working in and with pharma, biotech and healthcare.
Pfizer/BioNTech’s COVID-19 vaccine neutralises Brazil variant, suggests study
The companies are also in ongoing discussions with regulatory authorities regarding a clinical study to evaluate a variant-specific vaccine that would have a modified mRNA sequence. ... This study would use a new construction of the Pfizer/BioNTech
Latest news
-
MHRA to fast-track vaccines modified for new COVID-19 variants
A number of vaccine makers are working on modified vaccines to address new and emerging variants. ... This study would use a new construction of the Pfizer/BioNTech vaccine based on the B.1.351 variant, according to the companies.
-
Building a brighter future for rare disease patients
While a wealth of research knowledge exists within emerging pharma companies and university spin-outs, there tends to be less in-house experience of translating the science into compelling stakeholder value.
-
Novartis and J&J back latest €400m Medicxi biopharma fund
to Medicxi, with European companies growing in stature and offering improved returns on investment for backers. ... It added that investors are now “prioritising their attention and support for emerging biopharma companies and their efforts to
-
Biotech now vital to pipelines – but success rates falling
IQVIA picks out key trends to drive future productivity. The pharma sector is now well and truly the ‘biopharma industry’ with new data showing that biotech and emerging companies developing a ... The report found that so-called Emerging biopharma
-
Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate
Beigene is part of a wave of new China-based biotech companies who are emerging rapidly thanks to new rules in Hong Kong’s stock market, HKEX. ... A total of eight companies in biotech research have filed since May, and now Beigene is planning the
More from news
Approximately 0 fully matching, plus 53 partially matching documents found.
Latest Intelligence
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
This ‘speed chess’ approach could be a winning strategy for emerging biopharma companies (EBCs). ... Twitter has evolved and these smaller companies will have a bigger appetite for it.
-
Successful product commercialisation: what can we learn from the rare disease setting?
However, in addition to these internal drivers to improve agility, several external trends are also emerging. ... However, during our work with pharmaceutical companies launching products in rare diseases, one key characteristic stands out.
-
Pharma funding and M&A in 2020
traditional pharmaceutical companies look to increase innovation is through bolt-on acquisitions of more innovative players in the industry. ... As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast-
-
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China has long been an alluring country for global pharma companies whose mature investments are now being layered with a new wave of partnerships. ... China is still strong in chemistry and Me-Better drugs but there is a whole new generation of
-
Nudge-nudge, think-think
A common UX feature is goal- setting, but companies must dig deeper than bolting long-term treatment goals onto their programmes. ... There are, says Maria, good examples of more holistic and action-oriented interventions emerging from big pharma
More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Christie Anbar appointed global healthcare lead at Ruder Finn
In her new role, Anbar will lead the company’s partnership with clients ranging from major biopharmaceutical companies to emerging biotech, tech and health data pioneers, as well as patient advocacy ... In those roles, she led award-winning work for a
-
New hires at Abbott, Kite and Arrakis Therapeutics
chairman of its Board of Directors. She has nearly 30 years of experience in the biotech industry as a leader of emerging companies. ... Katrine’s experience building dynamic, science-driven companies will serve as a critical resource for Arrakis as we
-
Orchard Therapeutics appoints Mark Rothera as CEO
pipeline. Rothera brings 28 years’ experience in the biopharmaceutical industry including driving the transition of multiple emerging biotechnology companies from R&D stage to commercialisation, bringing rare disease therapies to the
-
Former Roche CEO and chairman joins Arix Bioscience
His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.
-
Bayer veteran joins Aurinia as CEO
Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences ... companies. “He is exceptionally
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering
industry. Two Labs helps pharmaceutical companies develop and execute customized launch strategies for products. ... Excellere Partners, a US-based private equity firm focused on partnering with entrepreneurs and management teams in emerging growth
-
Training the next generation of biotech leaders
This skills shortage is a major challenge for the sector. Currently, the number of biotech companies emerging is growing much faster than the talent pool. ... society. “We look at the manufacturing challenges we are facing for emerging healthcare
-
12 Connected Health
Seizing the opportunities in a new era of care. In recent decades, emerging technologies have repeatedly forced smart companies to answer the question: what’s new here and what’s our ... Today, smart pharma companies should be asking that same
-
Addison Whitney Health
Our work with established and emerging companies has created hundreds of strong, long-lasting brands.
-
Competition from within
Published in eyeforpharma July 29 by Rachel Howard. To what extent can Big Pharma expect to face an increasing challenge from globalizing pharmaceutical companies based in emerging markets? ... In ten years’ time, will more ‘home-grown’ emerging
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
- Saturnino Izquierdo takes on expanded role at McCann Health
- J&J delays EU COVID-19 vaccine rollout following pause in the US
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- UK trial evaluating mixed-vaccine regimens includes two more jabs
- Follow the user – democratising medical conference design
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- How a design mindset can lead to better medical outcomes
- By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
- How does the government plan to reshape the NHS?
- Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
Quick links
Infographics
